CBD isolate may reduce symptoms and progression of Parkinson’s disease – study
It also discovered it is potentially neuroprotective which could decrease the progression of the disease.
24 results for “isolate”
It also discovered it is potentially neuroprotective which could decrease the progression of the disease.
With novel food regulations coming into force this week there is much discussion in the industry about the various forms of CBD. Most of us know about the potential benefits […]
With so many CBD products on the market, do you know your distillates from your isolates? The experts at US manufacturer Fresh Bros break it down. Las Vegas manufacturer Fresh […]
Anxiety is one of the most common conditions for which medical cannabis is prescribed in the UK, but the evidence base remains mixed.
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
A comprehensive guide on how to read and interpret cannabis research.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over […]
New research suggests certain terpenes may be a viable medication for fibromyalgia and post-surgical pain relief.
Almost 400 families were found to be sourcing illegal cannabis products having been unable to get a prescription on the NHS.
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.